Evotec and BMS Secure Second FDA IND Acceptance
Hamburg, Germany, November 19, 2026 Evotec SE and Bristol Myers Squibb (BMS) have announced a significant milestone in their...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 Clinical Trial Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Hamburg, Germany, November 19, 2026 Evotec SE and Bristol Myers Squibb (BMS) have announced a significant milestone in their...
CAMBRIDGE, Massachusetts, U.S., October 29, 2026 Flagship Pioneering has announced the formation of Etcelera, a biotechnology company designed to...
SOUTH SAN FRANCISCO and SAN DIEGO — September 8, 2026 Moonwalk Biosciences announced the closing of an oversubscribed $70...
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
Cambridge, Massachusetts, August 10, 2026 Ernexa Therapeutics announced the appointment of David Polinsky to its Board of Directors as...
Vancouver, British Columbia, August 11, 2026 Genome BC has announced six research projects supported through its Data Access, Integration...
SILVER SPRING, Md. and NEW YORK, July 30, 2026 The TSC Alliance and Apertura Gene Therapy have announced the...
LONDON, July 30, 2026 Relation Therapeutics has announced an expanded strategic collaboration with GSK that will accelerate the use...
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
